Protagonist Therapeutics (PTGX) EBITDA Margin (QoQ) (2017 - 2026)
Protagonist Therapeutics (PTGX) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,062.00 |
| Dec 31, 2025 | 30,808.00 |
| Sep 30, 2025 | -22,712.00 |
| Jun 30, 2025 | -68,986.00 |
| Mar 31, 2025 | -14,502.00 |
| Dec 31, 2024 | 96,353.00 |
| Sep 30, 2024 | 4,426.00 |
| Jun 30, 2024 | -101,188.00 |
| Mar 31, 2024 | 3,482.00 |
| Jun 30, 2022 | -474,249.00 |
| Mar 31, 2022 | 34,750.00 |
| Dec 31, 2021 | -9,974.00 |
| Sep 30, 2021 | 103,362.00 |
| Jun 30, 2021 | -97,532.00 |
| Mar 31, 2021 | -5,485.00 |
| Dec 31, 2020 | -27,401.00 |
| Sep 30, 2020 | 23,375.00 |
| Jun 30, 2020 | 24,707.00 |
| Mar 31, 2020 | -130,655.00 |
| Dec 31, 2019 | 118,102.00 |